2212:
Allergic Rhinitis Medical Therapy/Immunotherapy/Venom Immunotherapy
Saturday, March 3, 2018: 9:45 AM-10:45 AM
Convention Center, South Concourse, Level 1, South Hall A2
Poster Session
0.00 CME/CE
212
Systemic Reactions To Aeroallergen Subcutaneous Immunotherapy In A Pediatric Practice
Megan K. Ford, MD Roslyn Whitley, MPH Magee L. DeFelice, MD
213
Preliminary indications regarding the safety and efficacy potential of allergen bearing bioparticles as an evolved form of immunotherapy
Guy Tropper, MD FRCSC Veronique M. Gomord, PhD Virginie Stordeur, M Sc Brian J Ward, MDCM Sébastien Viel, PharmD PhD Elizabeth D Fixman, PhD Anne-Catherine Fitchette, PhD Lorna Garnier Louis-Philippe Vézina, PhD Loic J-Y Faye, PhD
214
Allergen Immunotherapy for asthma in a public healthcare setting: The Cuban experience.
Alexis Labrada, PhD Maytee Mateo Morejon, MSc Wendy Ramirez Gonzalez, MSc Raul L. Castro Almarales, MD Mirta Alvarez Castello, MD
215
Cetirizine 5mg Provides Effective Relief of Worst Seasonal Allergy Symptoms in Children Ages 2-6 Years
Mitesh K Patel, PharmD Mei-Miau Mu, Dr PH Kathleen B. Franklin, BSN RN
218
Comparison of sensitisation to prevalent allergens in children vesus adolescents in the same geographical area.
Jose Alessandro Bastidas-Parlanti Damian López-Sánchez, MD Maria Luisa Somoza, MD Elisa Haroun Natalia Blanca-López, MD, PhD Laura Victorio-Puche, MD María Vazquez de la Torre, MD, PhD Maria Isabel Garcimartin, MD Miguel Blanca, MD PhD María Gabriela Canto, MD, PhD
219
Intranasal Association of Fluticasone propionate/Azelastine hydrochloride is Effective in Children with Allergic Rhinitis
Nelson Augusto Rosario, MD PhD FAAAAI Tatiane gs Scaliante Cristine S. Rosario, MD Herberto J. Chong Neto, MD PhD FAAAAI Carlos a Riedi
222
Effects of topical in vivo treatment on ovalbumin antibody production in mice
Greg A. Plunkett, PhD Henry J. Legere, MD FAAAAI Dennis Harris Peter Hurwitz, President Jose Toscano James Strader
223
Experimental Allergen Immunotherapy with Monomeric Allergoid From House Dust Mite Dermatophagoides pteronyssinus in a Mouse Model of Allergic Rhinitis
Alexander A. Babakhin, MD, PhD Anton A. Laskin Oleg Y Kamishnikov Denis G Chuvirov Svetlana V Khlgatyan Valentina M Berzhets Lawrence Dubuske Musa R Khaitov, MD PhD
224
Safety and Efficacy of a 12-week Maintenance Interval in Patients Treated with Imported Fire Ant Immunotherapy: An Interim Update
Rebecca Schapira, DO Kathryn P. Edwards, MD Derek M. Smith, MD Thad L. Ocampo, MD Shayne C. Stokes, MD Kevin Michael White, MD Kirk H. Waibel, MD FAAAAI Mike Tankersley, MD MBA FAAAAI Karla E. Adams, MD
See more of: Abstracts